BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 21544552)

  • 41. Doxorubicin as a fluorescent reporter identifies novel MRP1 (ABCC1) inhibitors missed by calcein-based high content screening of anticancer agents.
    Sampson A; Peterson BG; Tan KW; Iram SH
    Biomed Pharmacother; 2019 Oct; 118():109289. PubMed ID: 31401398
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The association of increased lung resistance protein expression with acquired etoposide resistance in human H460 lung cancer cell lines.
    Lee E; Lim SJ
    Arch Pharm Res; 2006 Nov; 29(11):1018-23. PubMed ID: 17146971
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efflux protein expression in human retinal pigment epithelium cell lines.
    Mannermaa E; Vellonen KS; Ryhänen T; Kokkonen K; Ranta VP; Kaarniranta K; Urtti A
    Pharm Res; 2009 Jul; 26(7):1785-91. PubMed ID: 19384462
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hedgehog signaling regulates drug sensitivity by targeting ABC transporters ABCB1 and ABCG2 in epithelial ovarian cancer.
    Chen Y; Bieber MM; Teng NN
    Mol Carcinog; 2014 Aug; 53(8):625-34. PubMed ID: 23423781
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs.
    Matsson P; Pedersen JM; Norinder U; Bergström CA; Artursson P
    Pharm Res; 2009 Aug; 26(8):1816-31. PubMed ID: 19421845
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
    Stein U; Lage H; Jordan A; Walther W; Bates SE; Litman T; Hohenberger P; Dietel M
    Int J Cancer; 2002 Feb; 97(6):751-60. PubMed ID: 11857350
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multidrug resistance proteins and other drug transport-related resistance to natural product agents.
    Broxterman HJ; Giaccone G; Lankelma J
    Curr Opin Oncol; 1995 Nov; 7(6):532-40. PubMed ID: 8547402
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The novel BCR-ABL and FLT3 inhibitor ponatinib is a potent inhibitor of the MDR-associated ATP-binding cassette transporter ABCG2.
    Sen R; Natarajan K; Bhullar J; Shukla S; Fang HB; Cai L; Chen ZS; Ambudkar SV; Baer MR
    Mol Cancer Ther; 2012 Sep; 11(9):2033-44. PubMed ID: 22778153
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT).
    Guo A; Marinaro W; Hu P; Sinko PJ
    Drug Metab Dispos; 2002 Apr; 30(4):457-63. PubMed ID: 11901101
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanisms of verapamil-enhanced chemosensitivity of gallbladder cancer cells to platinum drugs: glutathione reduction and MRP1 downregulation.
    Wang H; Li X; Chen T; Wang W; Liu Q; Li H; Yi J; Wang J
    Oncol Rep; 2013 Feb; 29(2):676-84. PubMed ID: 23229154
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hyperforin inhibits P-gp and BCRP activities in chronic lymphocytic leukaemia cells and myeloid cells.
    Quiney C; Billard C; Faussat AM; Salanoubat C; Kolb JP
    Leuk Lymphoma; 2007 Aug; 48(8):1587-99. PubMed ID: 17701591
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Knockdown of RLIP76 expression by RNA interference inhibits invasion, induces cell cycle arrest, and increases chemosensitivity to the anticancer drug temozolomide in glioma cells.
    Wang Q; Qian J; Wang J; Luo C; Chen J; Hu G; Lu Y
    J Neurooncol; 2013 Mar; 112(1):73-82. PubMed ID: 23292182
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation.
    Thiessen B; Stewart C; Tsao M; Kamel-Reid S; Schaiquevich P; Mason W; Easaw J; Belanger K; Forsyth P; McIntosh L; Eisenhauer E
    Cancer Chemother Pharmacol; 2010 Jan; 65(2):353-61. PubMed ID: 19499221
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro modulation of P-glycoprotein, MRP-1 and BCRP expression by mangiferin in doxorubicin-treated MCF-7 cells.
    Louisa M; Soediro TM; Suyatna FD
    Asian Pac J Cancer Prev; 2014; 15(4):1639-42. PubMed ID: 24641381
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer.
    Modok S; Mellor HR; Callaghan R
    Curr Opin Pharmacol; 2006 Aug; 6(4):350-4. PubMed ID: 16690355
    [TBL] [Abstract][Full Text] [Related]  

  • 57. (-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line.
    Farabegoli F; Papi A; Bartolini G; Ostan R; Orlandi M
    Phytomedicine; 2010 Apr; 17(5):356-62. PubMed ID: 20149610
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oct-3/4 modulates the drug-resistant phenotype of glioblastoma cells through expression of ATP binding cassette transporter G2.
    Hosokawa Y; Takahashi H; Inoue A; Kawabe Y; Funahashi Y; Kameda K; Sugimoto K; Yano H; Harada H; Kohno S; Ohue S; Ohnishi T; Tanaka J
    Biochim Biophys Acta; 2015 Jun; 1850(6):1197-205. PubMed ID: 25644290
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tie2-mediated multidrug resistance in malignant gliomas is associated with upregulation of ABC transporters.
    Martin V; Xu J; Pabbisetty SK; Alonso MM; Liu D; Lee OH; Gumin J; Bhat KP; Colman H; Lang FF; Fueyo J; Gomez-Manzano C
    Oncogene; 2009 Jun; 28(24):2358-63. PubMed ID: 19421150
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expressions of topoisomerase IIα and BCRP in metastatic cells are associated with overall survival in small cell lung cancer patients.
    Rijavec M; Silar M; Triller N; Kern I; Cegovnik U; Košnik M; Korošec P
    Pathol Oncol Res; 2011 Sep; 17(3):691-6. PubMed ID: 21455636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.